Condensin, one of the most abundant components of mitotic chromosomes, is a conserved protein complex composed of two structural maintenance of chromosomes (SMC) subunits (SMC2-and SMC4-type) and three non-SMC subunits, and it plays an essential role in mitotic chromosome condensation. Purified condensin reconfigures DNA structure using energy provided by ATP hydrolysis. To know the regulation of condensin in somatic cells, the expression level, subcellular localization, and phosphorylation status of human condensin were examined during the cell cycle. The levels of condensin subunits were almost constant throughout the cell cycle, and the three non-SMC subunits were phosphorylated at specific sites in mitosis and dephosphorylated upon the completion of mitosis. Subcellular fractionation studies revealed that a proportion of condensin was tightly bound to mitotic chromosomes and that this form was phosphorylated at specific sites. Condensin purified from mitotic cells had much stronger supercoiling activity than that purified from interphase cells. These results suggest that condensin functions in somatic cells are regulated by phosphorylation in two ways during the cell cycle; the phosphorylation of specific sites correlates with the chromosomal targeting of condensin, and its biochemical activity is stimulated by phosphorylation.
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family (4 -5) . The SMC2-SMC4 heterodimer forms a V-shaped structure with two long antiparallel coiled-coils. Condensin also contains three non-SMC subunits, CAP-D2, -G and -H, which bind to the ends of the SMC heterodimer (8 -9) . Genetic studies in the fission yeast Schizosaccharomyces pombe (10 -11) , the budding yeast Saccharomyces cerevisiae (12) (13) (14) (15) (16) , Drosophila melanogaster (17) (18) , and Caenorhabditis elegans (19 -20) reveal that each of the five subunits is essential for mitotic chromosome condensation and/or segregation in vivo. A biochemical study using Xenopus egg extracts also shows that all of the subunits are required for chromosome condensation in vitro (6 -7, 21) , and cytological analyses show that condensin has a structural role as a major component of the mitotic chromosomal scaffold (22) (23) .
The functions of condensin have been addressed extensively using Xenopus egg extracts in which it has been found that the condensin complex binds to chromosomes in a mitosis-specific manner and is required for the establishment and maintenance of chromosome condensation (6 -7) . The chromosomal localization of condensin is regulated by mitosis-specific phosphorylation (7) . Purified condensin binds directly to DNA in vitro and displays DNA-stimulated ATPase activity (21, 24) . In the presence of ATP, condensin promotes positive supercoiling in relaxed circular DNA with topoisomerase I (21, 24) , and it promotes positive 3-noded knots with topoisomerase II (25) . These activities are regulated by the mitosis-specific phosphorylation of the non-SMC subunits, which suggests that they may be physiologically relevant for mitotic chromosome condensation (26) . Recently, a study using electron spectroscopic imaging has revealed that a single condensin complex bound to DNA utilizes the energy of ATP hydrolysis to locally organize the DNA into two oriented supercoils (27) . Extensive analysis of condensin functions in fission yeast shows that the temperaturesensitive mutants cut3 and cut14, which have SMC subunit defects, fail to condense chromosomes during mitosis (10) . The phosphorylation of an N-terminal residue (Thr-19) of the Cut3 subunit by the cdc2 kinase is required for the accumulation of condensin in the nucleus and for chromosome condensation (11) . Curiously, the cnd2 mutant, which is defective in a non-SMC subunit, is impaired in the DNA excision repair pathway and in the activation of a checkpoint kinase as well as in condensation, indicating that condensin has interphase functions in addition to its mitotic functions (28) . A biochemical study revealed that the SMC heterodimer of fission yeast condensin efficiently promotes DNA reannealing from complementary single-stranded DNA to form double-stranded DNA (29) .
Less is known about human condensin than its Xenopus or fission yeast counterparts, but it has become the object of increasing attention. Human condensin consists of an SMC heterodimer (hCAP-C and hCAP-E) and three non-SMC subunits, hCAP-D2/CNAP1, hCAP-G, and hCAP-H (30 -32) . The cDNAs encoding the human condensin subunits have been cloned (30, 31, 33, 34) . In human cells condensin is constitutively expressed, but its localization is regulated in a cell cyclespecific manner; during interphase it is found predominantly in the cytoplasm, and during mitosis it associates with chromosomes (30, 35) . Condensin targets chromosomes during metaphase and dissociates from them during the anaphase-totelophase transition (23) . However, the mechanism by which condensin is targeted to chromosomes during mitosis is unknown. The human condensin complex can support chromosome condensation in Xenopus egg extracts that have been depleted of endogenous condensin (31) . The human condensin complex displays ATP-dependent supercoiling and knotting activities in vitro like its Xenopus counterpart but only when it is phosphorylated by cdc2-cyclin B (31). These two results suggest that there are functional similarities between the human and Xenopus condensin complexes. Nevertheless, there is no evidence that endogenous condensin complex purified from M phase cells can support supercoiling and knotting reactions. Moreover, it is totally unknown how human condensin functions are regulated by phosphorylation during the cell cycle in somatic cells.
In this study, we have focused on the relationship between phosphorylation and the mitosis-specific chromosomal targeting of the condensin complex. We have also precisely studied the correlation between phosphorylation and the biochemical activity of condensin during the cell cycle using synchronized HeLa cells.
EXPERIMENTAL PROCEDURES

Buffers
SDS buffer contains 50 mM Tris-HCl (pH 8.0), 0.6% SDS, and 1 mM dithiothreitol. Mild lysis buffer contained 0.1 M Na-P i (pH 7.2), 20 mM EDTA, 0.5 M NaF, 1% Nonidet P-40, and 0.25 M NaCl. CSK buffer contained 10 mM PIPES (pH 6.8), 100 mM NaCl, 300 mM sucrose, 3 mM MgCl 2 , 1 mM EGTA, 1 mM dithiothreitol, 0.25 mM phenylmethylsulfonyl fluoride, 10 mM NaF, 0.1 mM ATP, and the Complete protease inhibitor mixture set (Roche Applied Science). XBE2-gly contains 10 mM HEPES (pH 7.7), 100 mM KCl, 5 mM EGTA, 2 mM MgCl 2 , 0.1 mM CaCl 2 , and 10% glycerol. Hypotonic buffer contains 20 mM HEPES (pH 7.0), 50 mM NaCl, 0.1 mM EDTA, 10% glycerol, 1 mM dithiothreitol, 0.25 mM phenylmethylsulfonyl fluoride, and the Complete protease inhibitor mixture set (Roche Applied Science).
Peptide Antibody Preparation
Rabbit polyclonal antibodies were raised against synthetic peptides corresponding to the C-terminal sequences of each human condensin subunit, as described previously (31) . Immunization and affinity purification of antibodies were performed as described previously (7) .
Preparation of Cell Extracts
HeLa S3 cells were collected and washed twice with PBS(Ϫ) and frozen in N 2 liquid for stock. Cell extracts were prepared under nondenaturing or denaturing conditions as follows.
Nondenaturing Conditions-The frozen cells were thawed, suspended in CSK buffer containing 0.3% Triton X-100 and 0.3 M NaCl, and incubated at 4°C for 30 min. The suspension was separated by centrifugation for 10 min at 17,500 ϫ g, and the supernatant was recovered.
Denaturing Conditions-The frozen cells were thawed, suspended in SDS buffer, and boiled at 95°C for 10 min. Four volumes of mild lysis buffer were then added, the mixture was centrifuged for 90 min at 50,000 ϫ g, and the supernatant was recovered.
Cell Culture
HeLa S3 cells were cultured at 37°C in Dulbecco's modified Eagle's minimal essential medium containing 100 units/ml penicillin G potassium, 100 mg/ml streptomycin sulfate, and 5% calf serum.
Collection of Mitotic Cells
Logarithmically growing HeLa S3 cells from suspension cultures were inoculated in Dulbecco's modified Eagle's minimal essential medium containing 5% calf serum and 100 ng/ml TN-16 (Wako) at a concentration of 3 ϫ 10 5 cells/ml, incubated for 24 h to allow mitotic cells to accumulate, and harvested by centrifugation. The mitotic index of the cells collected in this method was greater than 90%. In some experiments, DNA content of the cells was measured with a laser scanning cytometer (Olympus).
Metabolic Labeling of the Cells
HeLa S3 cells (from suspension cultures) were labeled essentially as described previously (36) except that they were incubated for 2 h with 3 MBq/ml [ 
Immunoprecipitation
Cell extracts were prepared under nondenaturing or denaturing conditions as described above. Affinity-purified antibody (2 g) was added to the cell extracts, and the mixture was incubated at 4°C for 1 h. Protein A-Sepharose beads (5 l) were then added, and incubation was continued at 4°C for 1 h. The beads were washed 4 times with CSK buffer containing 0.3 M NaCl and 0.3% Triton X-100 (for extracts prepared under nondenaturing conditions) or with mild lysis buffer (for extracts prepared under denaturing conditions). The beads were then washed once with PBS(Ϫ), lysed in SDS sample buffer, and subjected to SDS-PAGE. When necessary, competing peptides were added to immunoprecipitation reactions at a final concentration of 0.05 mg/ml. For dephosphorylation experiments immunoprecipitates were incubated with 400 units of protein phosphatase (New England Biolabs) at room temperature for 30 min.
Subcellular Fractionation
HeLa S3 cells (1 ϫ 10 6 ) were lysed with 200 l of CSK buffer containing 0.3% Triton X-100 at 4°C for 30 min. The soluble and insoluble fractions were separated by centrifugation for 10 min at 2000 ϫ g. The supernatants were recovered as the chromatin-unbound fraction (Fig. 5A, Fr. 1 ). The insoluble fraction was suspended in 200 l of CSK buffer containing 200 units of DNase I, incubated at room temperature for 30 min, and clarified by centrifugation for 10 min at 17,500 ϫ g. The supernatants were recovered as the DNase-extractable fraction (Fig. 5A, Fr. 2) . The pellets were suspended in 200 l of CSK buffer containing 2 M NaCl and 0.3% Triton X-100 and centrifuged for 10 min at 17,500 ϫ g. The supernatants were saved as the high salt extractable fraction (Fig. 5A, Fr. 3) , and the pellets were saved as the high salt-resistant fraction (Fig. 5A, Fr. 4) . We consider the DNaseextractable and high salt-extractable fractions as chromatin-bound fractions.
Purification of Condensin Complexes
Purification of HeLa condensin was performed as described previously (31) with a minor modification. Briefly, extracts prepared from 2 ϫ 10 8 cells were mixed with 100 g of anti-hCAP-G antibody coupled to protein A-Sepharose beads (200 l) at 4°C for 1 h. The mixture was transferred to a 1-ml disposable column, washed successively with 16 ml of XBE2-gly, 2 ml of XBE2-gly containing 0.4 M KCl, and 2 ml of XBE2-gly. Condensin was eluted from the column by the addition of XBE2-gly containing 0.4 mg/ml antigen peptides.
Supercoiling Assay
The supercoiling assay was performed as described previously (24) except that relaxed circular 5-kilobase pGEX6p-1 DNA (Amersham Biosciences) was used as a substrate.
RESULTS
Protein Levels of Condensin Subunits Are Almost Constant through the Cell
Cycle-Condensin is a five-subunit protein complex that plays an essential role in mitotic chromosome condensation. Recently it has been shown that the subunit composition of condensin is also conserved in human cells (30 -31) , but little is known about its regulation during the cell cycle in somatic cells. We prepared peptide antibody against each condensin subunit to monitor the levels of condensin by immunoblot analysis (Fig. 1A) . When immunoprecipitation was performed on cellular extracts prepared under denaturing conditions, each antibody immunoprecipitated the corresponding subunit (Fig. 1C, lanes 1 , 3, 5, 7, and 9) . The specificity of the immunoprecipitation reaction was further confirmed by the addition of antigen peptides (Fig. 1C, lanes 2 , 4, 6, 8, and 10) . The five human condensin subunits were immunoprecipitated from whole cell extracts prepared under nondenaturing conditions by the anti-hCAP-E or anti-hCAP-G antibody, demonstrating that they associate with each other and form a complex in human cells similar to that observed in Xenopus egg extracts (Fig. 1B, lanes 1 and 3) .
First we compared the level of each condensin subunit in log phase cells and in M phase cells by quantitative immunoblot analysis. The DNA contents of these cells were determined with a laser-scanning cytometer ( Fig. 2A) . We detected little difference in the levels of condensin subunits between log phase and M phase cells (Fig. 2B) . We estimated that the hCAP-E subunit was present at 1 ϫ 10 6 copies per cell (data not shown). We next monitored the levels of each condensin subunit during the cell cycle. HeLa cells were released from an S phase block, allowed to proceed synchronously into M phase, and then released from M phase into G 1 phase. The progression of the cell cycle was monitored with a laser-scanning cytometer (Fig. 3A) . We found that the levels of hCAP-E and hCAP-G were almost constant throughout the cell cycle (Fig. 3B ).
Specific Sites on Human Condensin Are Phosphorylated during Mitosis-In
Xenopus egg extracts the three non-SMC subunits are hyperphosphorylated in a mitosis-specific manner, which regulates the in vitro activities of condensin (26) . On the other hand, the SMC4 subunit of fission yeast condensin is phosphorylated at its N terminus sites in mitosis, a modification that is required for the relocation of condensin into nucleus at this time (11) . Thus, it is likely that condensin functions are regulated by mitosis-specific phosphorylation but with different consequences for different species. In this study, we examined the phosphorylation status of human condensin subunits during the cell cycle. First, we compared log phase and M phase condensin. Condensin was immunoprecipitated from extracts prepared from log phase or M phase HeLa cells labeled with [ 32 P]orthophosphate, and the extent of phosphorylation was determined using an image analyzer. The subunit compositions of the two forms were indistinguishable, and four of the five subunits (hCAP-C, hCAP-D2, hCAP-G, and hCAP-H) were phosphorylated in both cases (Fig. 2C ). There was little difference in the overall levels of phosphorylation in log phase and M phase forms of condensin. This observation differs from what 2) and hCAP-G (lanes 3 and 4) . An antigenic peptide corresponding to hCAP-E (lane 2) or hCAP-G (lane 4) was added at 0.05 mg/ml to demonstrate the specificity of these reactions. Immunoprecipitates were recovered on protein A-Sepharose beads and subjected to SDS-PAGE followed by silver staining. C, immunoprecipitations (denaturing conditions) were performed on log phase extracts in the presence of SDS using affinitypurified peptide antibodies against hCAP-C (lanes 1 and 2), hCAP-D2 (lanes 3 and 4), hCAP-E (lanes 5 and 6), hCAP-G (lanes 7 and 8), and hCAP-H (lanes 9 and 10). The corresponding antigen peptides were added to 0.05 mg/ml to demonstrate the specificity of these reactions (lanes 2, 4, 6, 8, and 10) . The immunoprecipitates were analyzed by silver staining. ) . B, whole cell lysates prepared from log phase cells (lanes 1-3) and M phase cells (lanes 4 -6) were resolved by SDS-PAGE and subjected to immunoblot analysis with antibodies against hCAP-C, hCAP-D2, hCAP-E, hCAP-G, and hCAP-H. The amount of total proteins was 1.25 g (lanes 1 and 4) , 2.5 g (lanes 2 and 5), and 5 g (lanes 3 and 6) . C, cell extracts prepared from 32 P-labeled log phase cells (lanes 1 and 3) or mitotic cells (lanes 2 and 4) were immunoprecipitated with the anti-hCAP-E and the antihCAP-G antibodies. The precipitates were examined by SDS-PAGE and analyzed by silver staining (lanes 1 and 2) or with an image analyzer (BAS-2500 FUJI Photofilm) (lanes 3 and 4) . D, cell extracts prepared from log phase cells (lanes 1 and 2) and mitotic cells (lanes 3 and 4) were immunoprecipitated with the anti-hCAP-G antibody, left untreated (lanes 1 and 3) , or treated with lambda phosphatase (lanes 2 and 4) . The samples were immunoblotted using the phospho-specific monoclonal antibody MPM-2.
has been found for Xenopus egg extracts, where condensin is phosphorylated in a mitosis-specific manner. However, it remains possible that specific sites on human condensin are phosphorylated during M phase. To test this hypothesis, we carried out immunoblotting experiments using the phosphospecific monoclonal antibody MPM-2, which recognizes a class of mitosis-specific phosphoproteins (37) . We found that the hCAP-D2, hCAP-G, and hCAP-H subunits of M phase condensin acquired MPM-2 epitopes (Fig. 2D, lanes 1 and 3) . The specificity of the phosphorylation was confirmed further by treatment of protein fractions with phosphatase (Fig. 2D,  lanes 2 and 4) . Next we monitored changes in the MPM-2 epitopes of condensin subunits over the cell cycle. Analysis of synchronized cells showed that the frequency of hCAP-D2, hCAP-G, and hCAP-H subunits with MPM-2 epitopes increased in M phase cells and that these epitopes were lost when the cells exited M phase (Fig. 3C) . These results indicate that condensin is phosphorylated throughout the cell cycle but that specific sites (e.g. MPM-2 epitope sites) are phosphorylated in a mitosis-specific manner.
Turnover of Condensin Subunits Is Relatively Slow in HeLa Cells-We examined the life span of condensin subunits by pulse-chase analysis. First, [ 35 S]methionine-labeled log phase HeLa cells (2 h labeling) were transferred to label-free medium and harvested at various times. The hCAP-E and hCAP-G subunits of condensin were separately immunoprecipitated from extracts prepared under denaturing conditions and subjected to SDS-PAGE, and the 35 S label was detected using an image analyzer (Fig. 4A, upper) . The intensity of radioactivity was quantified to provide a degradation curve for each subunit (Fig. 4A, lower left) . The half-lives of the hCAP-E and hCAP-G subunits, as determined from semilog plots (Fig. 4A, lower  right) , were found to be 17 h (for the 0 -8-h interval) and 27 h (for the 8 -48-h interval) for hCAP-E and 18 h (0 -8 h) and 27 h (8 -48 h) for hCAP-G. Thus, newly synthesized condensin subunits were more stable after 8 h of the chase period (see "Discussion"). Next, the condensin complex was immunoprecipitated with the anti-hCAP-E or anti-hCAP-G antibody from [ 35 S]methionine-labeled cell extracts prepared in the absence of SDS. The 35 S labels were detected using an image analyzer (Fig. 4B, left) , and the decay curve of each subunit was plotted (Fig. 4B, right) . When the condensin complex was immunoprecipitated using the anti-hCAP-E antibody, the hCAP-C-specific label decreased in parallel with the hCAP-E-specific label, whereas the hCAP-D2-, hCAP-G-, and hCAP-H subunit-specific labels increased after 4 h of chase and then decreased. Alternatively, when immunoprecipitation was performed using the anti-hCAP-G antibody, the hCAP-C-and hCAP-E subunitspecific labels increased by about 250% after 8 h of chase and then decreased (see "Discussion"). Finally, we analyzed M phase cells labeled with [
35 S]methionine to examine the turnover of the hCAP-E and hCAP-G subunits during the transition from M phase to G 1 phase (Fig. 4C, left) . Most of the condensin subunits were stable, and about 86% of the hCAP-E protein and 75% of the hCAP-G protein were intact within 4 h after release from the M phase block (Fig. 4C, right) .
Chromosomal Targeting of Human Condensin Is Stimulated in M Phase and Correlates with M Phase-specific Phosphorylation-We next examined the subcellular localization of the hCAP-E and hCAP-G subunits in log phase and M phase cells by cell fractionation experiments. HeLa cells were successively treated with CSK buffer containing Triton X-100, with CSK buffer containing DNase I, and with CSK buffer containing 2 M NaCl (Fig. 5A) . Proteins not bound to chromatin were eluted by treatment with CSK buffer containing Triton X-100 (Fr. 1), and proteins bound to chromatin were recovered from the DNase I (Fr. 2)-and high salt-treated (Fr. 3) fractions. Most of the hCAP-E and hCAP-G subunits were found in the chromatinunbound fraction in log phase cells, but some of these proteins were also found in the DNase I-and high salt-treated fractions in M phase cells (Fig. 5B) . We estimate that about 24% of the hCAP-E and 25% of the hCAP-G subunits are present in chromatin-bound fractions in M phase cells (Fig. 5C ). As a positive control for subcellular fractionation, we carried out immunoblot analysis with antibodies to histone H3, anti-lamin B1, and anti-Mcm7 (data not shown). It has been reported that the phosphorylation of fission yeast condensin by the cdc2 kinase may facilitate its nuclear localization during mitosis (11) . The site that is phosphorylated in fission yeast condensin is not conserved in the human counterpart; however, it is still possible that the chromosomal targeting of human condensin is also regulated by phosphorylation. Therefore, we compared the degree of phosphorylation of M phase condensin purified from the chromatin-unbound fraction and that purified from the chromatin-bound fraction. Unexpectedly, we found no significant difference in the extent of 32 P labeling between the two forms (Fig. 5D, lanes 3 and 4) . However, the hCAP-G and hCAP-H subunits of only the chromatin-bound form of condensin acquired MPM-2 epitopes (Fig. 5D, lanes 7 and 8) , whereas the hCAP-D2 subunit present in both forms of condensin had MPM-2 epitopes (Fig. 5D, lanes 7 and 8) .
The Supercoiling Activity of Condensin Purified from HeLa Cells Is Mitosis-specific-Xenopus condensin purified from mitotic egg extracts introduces positive supercoils into relaxed circular DNA in vitro in the presence of ATP and topoisomerase I (26). Human condensin also displays supercoiling activity FIG. 3 . Protein level and phosphorylation of condensin subunits through the cell cycle. HeLa cells were accumulated in early S phase in the presence of aphidicolin and allowed to proceed through S phase after its removal. At 8 h TN-16 was added at a final concentration of 100 ng/ml to accumulate the cells in M phase, and at 16 h TN-16 was removed from the medium to release the cells into G 1 phase. A, the DNA contents of the HeLa cells were determined with a laser scanning cytometer. The times after the release from S phase block were 0 h (lane
1), 4 h (lane 2), 8 h (lane 3), 10 h (lane 4), 12 h (lane 5), 14 h (lane 6), 16 h (lane 7), 17 h (lane 8), 18 h (lane 9), and 20 h (lane 10)
. B, whole cell extracts (5 g of total protein) were resolved by SDS-PAGE followed by immunoblot analysis using antibodies against each condensin subunit. The times after the release from S phase block were the same as in A. C, whole cell extracts were immunoprecipitated by the anti-hCAP-E and anti-hCAP-G antibodies, and the immunoprecipitates were immunoblotted with the phospho-specific monoclonal antibody MPM-2. The time after the release from the S phase block was the same as in A. An asterisk indicates a nonspecific signal independent of the condensin subunits.
FIG. 4. Turnover of condensin subunits. A, [
35 S]methionine-labeled log phase cells (2-h labeling) were transferred to label-free medium and harvested at the indicated times. The hCAP-E or hCAP-G subunit was immunoprecipitated individually from whole cell extracts prepared in the presence of SDS, and the 35 S label was visualized using an image analyzer (upper). The decay curves of hCAP-E (green triangle) and hCAP-G (yellow circle) are shown (lower left). Decay rates were determined from semilog plots (lower right panel (left, hCAP-E; right, hCAP-G)). B, [ 35 S]methionine labeling of cells was performed in the same manner as in A. The condensin complex was immunoprecipitated (IP) with anti-hCAP-E (upper left) or anti-hCAP-G (lower left) in the absence of SDS, and the 35 S signal was visualized using an image analyzer. The asterisk indicates a nonspecific signal unrelated to condensin subunits. The decay curve of each condensin subunit is shown (upper right; lower right). C, [ 35 S]methionine-labeled M phase cells were transferred into label-and TN-16-free media and harvested at the indicated times. The hCAP-E or hCAP-G subunit was immunoprecipitated individually from cell extracts prepared under denaturing conditions, and the 35 S label was detected using an image analyzer (left). The decay curves of hCAP-E (green triangle) and hCAP-G (yellow circle) are shown (right).
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when it is phosphorylated by cdc2-cyclin B (31). To address whether an endogenous complex purified from cell extracts has this activity we purified condensin from log phase or M phase cell extracts and examined the status of phosphorylation and the supercoiling activity of the two forms (Fig. 6 ). Immunoblot analysis showed that the hCAP-D2 subunit of M phase condensin was recognized by the MPM-2 monoclonal antibody, suggesting that purified M phase condensin is phosphorylated at a specific site(s) (Fig. 6A) . This result is a little different from what was found in immunoprecipitation experiments, which showed that the hCAP-G and hCAP-H subunits also had MPM-2 epitopes. However, it is possible that there had been MPM-2 epitope sites in hCAP-G, and hCAP-H but that they were dephosphorylated during purification. We found that M phase condensin had a more than four times greater supercoiling activity than log phase condensin (Fig. 6B, upper) ; the average linking number of the substrate DNA changed by ϩ0.4 in the presence of log phase condensin and by ϩ1.7 in the presence of M phase condensin when the molar ratio of protein to DNA was 58 and measured to be ϩ1.0 with the log phase condensin and ϩ4.5 with the M phase condensin when the molar ratio of protein to DNA was 116. In contrast, the DNA binding activity of log phase condensin was almost the same as that of M phase condensin (Fig. 6B, lower) . Next, we examined the level of the MPM-2 epitopes and the supercoiling activity of condensin during the transition from M to G 1 phase. Cells were released from an M phase arrest and harvested at 0, 1, 2, and 4 h thereafter. Purified condensin from these cells was assayed for reactivity with the MPM-2 antibody (Fig. 6C, middle) and for supercoiling activity (Fig. 6C, top) . In proportion to the decrease in the number of M phase cells, the hCAP-D2 subunit lost an MPM-2 epitope, and condensin lost supercoiling activity. These results indicate that the supercoiling activity of human condensin, like Xenopus condensin, is regulated by mitosis-specific phosphorylation. Finally, in a pulse-chase experiment using M phase cells labeled with [ 32 P]orthophosphate, we examined the turnover of phosphates attached to condensin subunits during the transition from M phase to G 1 phase. We found that a considerable proportion of the phosphates attached to condensin during M phase were removed when the cells exited from M phase (Fig. 6D ).
DISCUSSION
The condensin complex is a conserved five-subunit protein complex that plays an essential role in mitotic chromosome condensation (4 -5) . The function of condensin has been extensively characterized in a cell-free system using Xenopus egg extracts. Condensin is targeted to chromosomes in a mitosisspecific manner and induces mitotic chromosome condensation in Xenopus egg extracts (7) . Condensin purified from mitotic Xenopus egg extracts reconfigures DNA structure in the presence of ATP (e.g. supercoiling activity and knotting activity) (24 -26) . Recently, a human condensin complex was identified and shown to have a subunit composition similar to that of the Xenopus counterpart (30 -32) . Like the Xenopus complex, human condensin can functionally complement Xenopus egg extracts depleted of intrinsic condensin, and it displays supercoiling and knotting activities when phosphorylated by cdc2-cyclin B, suggesting that condensin complexes from the two species share functional similarities (31) . However, little is known concerning the cell cycle regulation of the condensin complex in mammalian somatic cells. In this study, we used synchronized HeLa cells to examine the level, stability, subcellular localization, phosphorylation, and activation of condensin during the cell cycle.
Protein Levels and Stabilities of Condensin Subunits during the Cell Cycle-The major functions of condensin appear to be mitosis-specific. Therefore, we first determined whether condensin was regulated at the protein level. We confirmed by quantitative immunoblot analysis that the amount of condensin is constant through the cell cycle. This result is consistent with previous reports that the level of the hCAP-H subunit 1 and 3) and chromatin-bound fractions (B; lanes 2 and 4) prepared from 32 P-labeled M phase HeLa cells were immunoprecipitated with the hCAP-G antibody. The samples were analyzed by silver staining (lanes 1 and 2) or with an image analyzer (lanes 3 and 4) . Alternatively, chromatin-unbound fractions (lanes 5 and 7) and chromatin-bound fractions (lanes 6 and 8) prepared from non-labeled M phase HeLa cells were immunoprecipitated with the anti-hCAP-E and the anti-hCAP-G antibodies. The samples were immunoblotted with the anti-hCAP-C, anti-hCAP-D2, anti-hCAP-E, anti-hCAP-G, and anti-hCAP-H antibodies (␣con, lanes 5 and 6) or the phospho-specific monoclonal antibody MPM-2 (lanes 7 and 8).
does not change through the cell cycle, as shown by immunoblot analysis (35) , and that the condensin subunit(s) are present throughout the cell cycle, as shown by immunofluorescence analysis (30, 35) . In contrast, hCAP-H mRNA has been reported to be transcribed during G 2 and degraded upon exit from mitosis (35) , which seems unusual given that the hCAP-H protein is present during interphase. Cabello et al. (35) reason that the steady-state pool of the hCAP-H protein may be greater than the cycling pool resulting from the premitotic hCAPH transcription in mammalian cells. We performed pulse-chase experiments and found that hCAP-E, an SMC subunit, and hCAP-G, a non-SMC subunit, are relatively stable (Fig. 4A) . The long lives of the condensin subunits may be one reason why the level of condensin is constant throughout the cell cycle despite its mitosis-specific transcription.
The stabilities of the condensin subunits are different in the first 8 h of the chase period and in the period thereafter. The half-lives of hCAP-E are 17 h (for the 0 -8-h interval) and 27 h (8 -48 h) and of hCAP-G are 18 h (0 -8 h) and 27 h (8-48 h) (Fig. 4A) . Thus, condensin subunits become more stable after 8 h of the chase (see below). We also immunoprecipitated the condensin complex with anti-hCAP-G and anti-hCAP-E antibody from log phase cells that had been labeled with [ 35 S]methionine and determined the amount of label associated with each condensin subunit at various times after the chase (Fig.  4B) . We found that in complexes immunoprecipitated by the anti-hCAP-E antibody, the amounts of label specific to the hCAP-C and hCAP-E subunits was reduced, but the amount of label specific to the hCAP-D2, hCAP-G, and hCAP-H subunits increased and reached a maximal level in 4 h. In contrast, when we immunoprecipitated the condensin complex with the antihCAP-G antibody, the amount of label specific to the hCAP-H subunit decreased in parallel with that of the hCAP-G subunit, but the amount of label specific to the hCAP-C and hCAP-E subunits increased and reached a maximal level by 8 h and then decreased. HeLa cells were [
35 S]methionine pulse-labeled for 2 h, and the label was then removed. Therefore, if condensin complexes had rapidly assembled from newly synthesized subunits during this period, the amount of label in each subunit should have decreased at the same rate. This was not the case. We speculate that it takes 4 -8 h for complexes to form from newly synthesized subunits, since the extent of 35 S labeling of some of the condensin subunits increased during this period. We suggest that this is why the half-lives of condensin subunits change after 8 h (Fig. 5A) ; the subunits may become more stable once they are incorporated into the complex. We consider that hCAP-C and hCAP-E immediately bind each other after synthesis, because the extent of hCAP-C 35 S-labeling decreased in parallel with that of hCAP-E when condensin was immunoprecipitated by the anti-hCAP-E antibody and because fluctuations in the level of label specific to the hCAP-C and hCAP-E subunits were similar when condensin was immunoprecipi- FIG. 6 . Cell-cycle dependent supercoiling activity of human condensin. A, human condensin was purified from log phase (lanes 1-3) or M phase (lanes 4-6) HeLa cell extracts followed by immunoblot analysis using the anti-hCAP-E and antihCAP-G antibodies (upper) or the monocolonal antibody MPM-2 (lower). The amount of the hCAP-E subunit was 100 ng (lanes 1 and 4), 200 ng (lanes 2 and 5) , or 400 ng (lanes 3 and 6) . B, supercoiling (upper panel) and gel-shift (lower panel) assays were performed using increasing amounts of condensin purified from log phase cells (lanes 2-5) or M phase cells (lanes 7-10) . The molar ratios of condensin to DNA were 29:1 (lanes 2 and 7) , 58:1 (lanes 3 and 8) , 116:1 (lanes 4 and 9) , or 232:1 (lanes 5 and 10) . tated by the anti-hCAP-G antibody. This interpretation is consistent with the observation that a proportion of hCAP-C and hCAP-E is present as a stable SMC heterodimer in HeLa cells as well as in Xenopus egg extracts (7, 31) . We also analyzed the stabilities of the hCAP-E and hCAP-G subunits during the transition from M to G 1 phase. Both subunits were stable; only 14% of hCAP-E protein and 25% of hCAP-G proteins disappeared within 4 h of release from an M phase block. Thus, the stabilities of the condensin subunits do not decrease significantly during this period.
Changes in the Subcellular Localization of Condensin Subunits-We carried out fractionation of log phase and M phase cells (Fig. 5A ) and examined the subcellular localization of the hCAP-E and hCAP-G subunits (Fig. 5B) . The majority of both subunits was found in the chromatin-unbound fraction of log phase cells, and a proportion of each was bound to chromosomes in M phase cells. These results are consistent with observations made by immunofluorescence analysis (23, 30, 35) . The percentages of the chromatin-bound fraction of hCAP-E and hCAP-G were 24 and 25%, respectively. Because the protein level of hCAP-E was 1 ϫ 10 6 copies per cell, we roughly estimate that 1 hCAP-E subunit is bound per 13 kilobases DNA in mitotic chromosomes. This value is similar to that found for fission yeast (1 Cut3-Cut14 complex per 8 kilobases DNA) (29) or for Xenopus egg extracts (1 condensin complex per 5-10 kilobases of DNA) (24) . It has been reported that a minor population of condensin localizes as distinct foci to the nucleolus and to chromatin in interphase cells (30, 35) . In this experiment we found that only a small proportion of condensin is present in the chromatin-bound fraction in log phase cells.
The molecular mechanism underlying the mitosis-specific chromosomal localization of condensin in mammalian cells is not well understood. One possibility is that this targeting is regulated by mitosis-specific phosphorylation. In Xenopus egg extracts, the chromosomal localization of condensin is regulated by the ratio of kinase to phosphatase. The extent of targeting correlates with the degree of phosphorylation of the three non-SMC subunits (7) . In fission yeast phosphorylation of an N-terminal residue (Thr-19) of the Cut3 (SMC4) subunit by cdc2 kinase is required for the accumulation of condensin in the nucleus during mitosis (11) . However, this phosphorylation site is not conserved in human condensin. In Drosophila and C. elegans depletion of the aurora B kinase by RNA interference causes a defect in the loading of condensin onto mitotic chromosomes (20, 38, 39) . However, chromosomally bound condensin is not affected by the depletion of aurora B kinase from Xenopus egg extracts (40) . Thus, although it is likely that the binding of condensin to mitotic chromosomes is regulated by phosphorylation, the corresponding kinase(s) that is involved in this process or the exact role of phosphorylation is not understood. We determined whether there was a difference in the degree of phosphorylation in condensin in the chromatinunbound fraction and in the chromatin-bound fraction. No significant difference in 32 P labeling was found between the two forms (Fig. 5D, lanes 3 and 4) . However, the hCAP-G and hCAP-H subunits in the chromatin-bound form acquired MPM-2 epitopes, whereas those in the chromatin-unbound form did not (Fig. 5D, lanes 7 and 8) . Because MPM-2 is a monoclonal antibody that recognizes mitosis-specific phosphoepitopes (37) , it is likely that the mitosis-specific chromosomal targeting of condensin is regulated by the phosphorylation of specific site(s) in hCAP-G and/or hCAP-H. However, we cannot exclude the possibility that the hCAP-G and hCAP-H subunits are phosphorylated at the MPM-2 epitope sites on mitotic chromosomes.
Phosphorylation and Activation of Human Condensin during
the Cell Cycle-To examine the level of phosphorylation of condensin we purified the complex from log phase or M phase extracts prepared from [ 32 P]orthophosphate-labeled HeLa cells. The hCAP-C (SMC4), hCAP-D2, hCAP-G, and hCAP-H subunits of condensin were phosphorylated. There was little difference in the degree of phosphorylation between the log phase and M phase forms of condensin (Fig. 2C ). This result is unexpected because it has been reported that the three non-SMC subunits of Xenopus condensin are phosphorylated in a mitosis-specific manner in cell-free extracts (7) . However, when immunoblot analysis was performed using the MPM-2 monoclonal antibody, the hCAP-D2, hCAP-G, and hCAP-H subunits purified from M phase cells were found to have acquired MPM-2 epitopes (Fig. 2D) . Therefore, it is likely that human condensin is phosphorylated at specific sites in M phase cells, although the overall phosphorylation levels of log phase and M phase condensin are similar.
We found that human condensin purified from M phase cells has supercoiling activity that is more than four times greater than that purified from log phase cells (Fig. 6B ). This enhanced activity parallels the accumulation of M phase cells and the phosphorylation of MPM-2 epitope sites (Fig. 6C) . This is the first finding that the endogenous human condensin complex, like its Xenopus counterpart, undergoes a mitosis-specific increase in supercoiling activity. We propose that the cdc2 kinase may phosphorylate and stimulate condensin in human somatic cells during mitosis because it has been reported that the supercoiling activity of human condensin is stimulated by the cdc2 kinase in vitro (31) and because human condensin acquires MPM-2 epitopes after phosphorylation by this kinase (data not shown). Nevertheless, the involvement of other mitotic kinase(s) in the stimulation of condensin activity cannot be ruled out, because the supercoiling activity of interphase Xenopus condensin is not fully restored to mitotic levels by phosphorylation by the cdc2 kinase (25) . Thus, other kinase(s) may be required for the full activation of condensin.
Finally, what is the significance of the phosphorylation of interphase condensin? Recently, it has been reported that condensin also has roles during interphase in the excision repair pathway, the activation of the DNA damage checkpoint, and gene silencing (41) . Therefore, it is possible that the phosphorylation of interphase condensin may regulate these functions. Further extensive analysis of the phosphorylation of condensin should provide more insights into the functions of this ubiquitous complex.
